Pharmacology of Ocular Complications

Kador, P.

Abstract

The events leading to the onset of various ocular complications are being studied in addition to methods for their potential pharmacological control. Specifically, the relationships between the enzymes aldose reductase and aldehyde reductase and the progression of retinopathy, cataract, pupil function and iris changes, and keratopathy induced by diabetes or galactosemia are being investigated. Methods for either delaying or preventing the onset of these complications through the pharmacological control of these enzymes are also being developed. The biochemical progression of several types of cataracts are also being studied as well as methods for controlling their onset through pharmacological intervention.

Funding Agency

• Agency: National Institute of Health (NIH)
• Institute: National Eye Institute (NEI)
• Type: Intramural Research (Z01)
• Project #: 1Z01EY000003-16
• Application #: 3941612
• Support Year: 16
• Fiscal Year: 1987

Institution

• Name: U.S. National Eye Institute
• Country: United States

Publications

Schlitzer, M; Rodriguez, L; Kador, P F (2001) Synthesis of potential aldose reductase inhibitors based on minimal pharmacophore requirements. J Pharm Pharmacol 53:831-9

Murata, M; Ohta, N; Sakurai, S et al. (2001) The role of aldose reductase in sugar cataract formation: aldose reductase plays a key role in lens epithelial cell death (apoptosis). Chem Biol Interact 130-132:617-25

Mizoguchi, T; Maeda, I; Yagi, K et al. (2001) Effect of bovine small intestine thioredoxin on aldose reductase activity. Chem Biol Interact 130-132:609-15

Sugiyama, K; Chen, Z; Lee, Y S et al. (2000) Isolation of a non-covalent aldose reductase-nucleotide-inhibitor complex. Biochem Pharmacol 59:329-36

Murata, M; Kador, P F; Sato, S (2000) Vascular endothelial growth factor (VEGF) enhances the expression of receptors and activates mitogen-activated protein (MAP) kinase of dog retinal capillary endothelial cells. J Ocul Pharmacol Ther 16:383-91

Kador, P F; Lee, J W; Fujisawa, S et al. (2000) Relative importance of aldose reductase versus nonenzymatic glycosylation on sugar cataract formation in diabetic rats. J Ocul Pharmacol Ther 16:149-60

Lizak, M J; Datiles, M B; Aletras, A H et al. (2000) MRI of the human eye using magnetization transfer contrast enhancement. Invest Ophthalmol Vis Sci 41:3878-81

Sato, S; Sugiyama, K; Lee, Y S et al. (1999) Prevention of naphthalene-1,2-dihydrodiol-induced lens protein modifications by structurally diverse aldose reductase inhibitors. Exp Eye Res 68:601-8

Sugiyama, K; Wang, T C; Simpson, J T et al. (1999) Aldose reductase catalyzes the oxidation of naphthalene-1, 2-dihydrodiol for the formation of ortho-naphthoquinone. Drug Metab Dispos 27:60-7

Ohta, N; Tsai, J Y; Secchi, E F et al. (1999) Neutrophils in galactose-fed dogs: suppressed apoptosis and increased adhesion to retinal capillary endothelial cells. J Diabetes Complications 13:151-8